About Contact Us Careers
Sign In

Nonvenereal Syphilis Treatment Market - Top Companies and Manufacturers

  • Report ID: 3569
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Companies Dominating the Nonvenereal Syphilis Treatment Landscape

    • Pfizer, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Novartis International AG
    • Sanofi S.A.
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Otsuka Pharmaceutical Co., Ltd.,
    • Abbott Laboratories
    • Cipla Limited
Browse Key Market Insights with Data Illustration:

In the News

  • Cipla Limited a multinational pharmaceutical company joint hands with Kemwell Biopharma Private Limited, a leading global CDMO, to make cost-effective biotherapeutics.

  • Sandoz, a subsidiary of Novartis, expanded its portfolio in manufacturing antibiotics with the acquisition of the Cephalosporin antibiotics business of GSK.


Author Credits:  Radhika Pawar


  • Report ID: 3569
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of nonvenereal syphilis treatment is estimated at USD 381.03 million.

The nonvenereal syphilis treatment market size was over USD 332.06 million in 2024 and is anticipated to cross USD 1.01 billion by 2037, growing at more than 8.9% CAGR during the forecast period i.e., between 2025-2037. The rising cases of bejel as well as the increasing augmentation of infectious diseases will drive the market growth.

Middle East and Africa industry is likely to hold largest revenue share by 2037, attributed to existence of nonvenereal syphilis in regions of West Africa, the Mediterranean, and the Sahara propelled by lack of sanitization as well as the hot and humid climate.

The major players in the market are Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis International AG, Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Cipla Limited
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample